EXEL vs. CRSP
Compare and contrast key facts about Exelixis, Inc. (EXEL) and CRISPR Therapeutics AG (CRSP).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EXEL or CRSP.
Correlation
The correlation between EXEL and CRSP is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
EXEL vs. CRSP - Performance Comparison
Key characteristics
EXEL:
1.67
CRSP:
-0.70
EXEL:
2.51
CRSP:
-0.94
EXEL:
1.35
CRSP:
0.90
EXEL:
0.98
CRSP:
-0.45
EXEL:
9.22
CRSP:
-1.40
EXEL:
6.27%
CRSP:
27.31%
EXEL:
34.69%
CRSP:
54.85%
EXEL:
-97.38%
CRSP:
-85.11%
EXEL:
-27.43%
CRSP:
-81.52%
Fundamentals
EXEL:
$9.88B
CRSP:
$3.37B
EXEL:
$1.76
CRSP:
-$4.34
EXEL:
2.27
CRSP:
-0.21
EXEL:
$1.74B
CRSP:
$36.12M
EXEL:
$1.69B
CRSP:
-$32.01M
EXEL:
$650.08M
CRSP:
-$311.55M
Returns By Period
In the year-to-date period, EXEL achieves a 7.33% return, which is significantly higher than CRSP's -1.40% return.
EXEL
7.33%
-2.48%
36.20%
56.69%
14.47%
27.74%
CRSP
-1.40%
-7.86%
-18.85%
-36.03%
-4.23%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EXEL vs. CRSP — Risk-Adjusted Performance Rank
EXEL
CRSP
EXEL vs. CRSP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Exelixis, Inc. (EXEL) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
EXEL vs. CRSP - Dividend Comparison
Neither EXEL nor CRSP has paid dividends to shareholders.
Drawdowns
EXEL vs. CRSP - Drawdown Comparison
The maximum EXEL drawdown since its inception was -97.38%, which is greater than CRSP's maximum drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for EXEL and CRSP. For additional features, visit the drawdowns tool.
Volatility
EXEL vs. CRSP - Volatility Comparison
The current volatility for Exelixis, Inc. (EXEL) is 9.64%, while CRISPR Therapeutics AG (CRSP) has a volatility of 23.47%. This indicates that EXEL experiences smaller price fluctuations and is considered to be less risky than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
EXEL vs. CRSP - Financials Comparison
This section allows you to compare key financial metrics between Exelixis, Inc. and CRISPR Therapeutics AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities